Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Plasma homocysteine levels in patients with multiple sclerosis in the Greek population.
Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis.
Anxiety state affects information processing speed in patients with multiple sclerosis.
Attributional style and depression in multiple sclerosis: the learned helplessness model.
From the fundamentals of multiple sclerosis to clinical management.
Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders.
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.
Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study.
CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice.
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
Management of multiple sclerosis.
Vagomimetic effects of fingolimod: physiology and clinical implications.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
LINGO-1 Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments.
The Wnt Effector Transcription Factor 7-Like 2 Positively Regulates Oligodendrocyte Differentiation in a Manner Independent of Wnt/β-Catenin Signaling.
Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
Treatment of acute optic neuritis and vision complaints in multiple sclerosis.
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?].
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.
Current topics in therapeutic plasmapheresis.

Pages